Advanced Malignancies: Testing DSB2455

We are assessing a new anti-cancer treatment, DSB2455, for patients with advanced malignancies. The goal is to understand how well it works when given alone.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Oncologie médicale
Bordeaux, France
Institut Godinot
Oncologie médicale
Cormontreuil, France
Hospital Hm Nou Delfos
Oncology START Barcelona – HM Nou Delfos
Barcelona, Spain

Sponsor: Duke Street Bio Limited
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.